RSS
Press Releases
Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
Basel, March 29, 2026 – Novartis today announced final two-year results from the Phase III APPLAUSE‑IgAN study of Fabhalta® (iptacopan) in IgA nephropathy (IgAN). Fabhalta demonstrated a statistically significant, clinically meaningful improvement in estimated glomerular filtration rate (eGFR) slope, a key marker of kidney function, compared with placebo1. Fabhalta consistently outperformed placebo across key kidney…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 and November 4, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2026 lead plaintiff deadline.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto presale crossed $8.47 million after its latest presale round closed ahead of schedule, and the crypto news connecting this project to the BNB price prediction tells a story every BNB holder needs to understand.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
Largo, FL, March 28, 2026 (GLOBE NEWSWIRE) -- This release reflects growing consumer discussions and publicly available information surrounding the viral "gelatin trick" trend in 2026. It is intended for informational purposes and does not represent independent product testing, evaluation, or third-party review of any product referenced. All product details described below are stated as…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
CAMBRIDGE, Mass., March 28, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced positive results from the Phase 2 part of the AMETHYST Phase 2/3 study (Part A) of litifilimab in people living with cutaneous lupus erythematosus (CLE). Litifilimab is the first humanized IgG1 monoclonal antibody (mAb) targeting blood dendritic cell antigen 2 (BDCA2), which…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hitek Global Inc. (NASDAQ: HKIT) resulting from allegations that Hitek Global Inc. may have issued materially misleading business information to the investing public.
Globe NewsWire News Distribution Service Article Count: 1828
Media Partner Network Article Count: 4
Send2Press NewsWire Distribution Service Article Count: 684
Related Product Search/Búsqueda de productos relacionados
